How to use... microarray comparative genomic hybridisation to investigate developmental disorders

Archives of Disease in Childhood: Education and Practice Edition

Volumn 100, Issue 1, 2015, Pages 24-29

  Kharbanda, Mira ^a   Tolmie, John ^a   Joss, Shelagh ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTISM; CHROMOSOME STRUCTURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; EPILEPSY; EXOME; FACE DYSMORPHIA; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOME; GROWTH DISORDER; HUMAN; KARYOTYPE; KARYOTYPING; LEARNING DISORDER; MICROARRAY ANALYSIS; PRIORITY JOURNAL; QUALITATIVE RESEARCH; CHILD; DEVELOPMENTAL DISABILITIES; DNA MICROARRAY; PROCEDURES;

CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISABILITIES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84921644447     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/archdischild-2014-306022     Document Type: Article

References (18)

1. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64.
2. Cooper GM, Coe BP, Girirajan S, et al. A copy number variation morbidity map of developmental delay. Nat Genet 2011;43:838-46.
3. Beaudet AL. The utility of chromosomal microarray analysis in developmental and behavioral pediatrics. Child Dev 2013;84:121-32.
4. Conrad DF, Pinto D, Redon R, et al. Origins and functional impact of copy number variation in the human genome. Nature 2010;464:704-12.
5. Mefford HC, Eichler EE. Duplication hotspots, rare genomic disorders, and common disease. CurrOpin Genet Dev 2009;19:196-204.
6. Macdonald JR, Ziman R, Yuen RK, et al. The database of genomic variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 2014;42(Database issue): D986-92.
7. Swaminathan GJ, Bragin E, Chatzimichali EA, et al. DECIPHER: web-based, community resource for clinical interpretation of rare variants in developmental disorders. Hum Mol Genet 2012;21(R1):R37-44.
8. Nowakowska BA, de Leeuw N, Ruivenkamp CA, et al. Parental insertional balanced translocations are an important cause of apparently de novo CNVs in patients with developmental anomalies. Eur J Hum Genet 2012;20:166-70.
9. Kaminsky EB, Kaul V, Paschall J, et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genet Med 2011;13:777-84.
10. Girirajan S, Brkanac Z, Coe BP, et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011;7:e1002334.
11. Girirajan S, Rosenfeld JA, Coe BP, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med 2012;367:1321-31.
12. Vulto-van Silfhout AT, Hehir-Kwa JY, van Bon BWM, et al. Clinical significance of de novo and inherited copy-number variation. Hum Mutat 2013;34:1679-87.
13. Ahn JW, Bint S, Bergbaum A, et al. Array CGH as a first line diagnostic test in place of karyotyping for postnatal referrals-results from four years' clinical application for over 8,700 patients. Molecular Cytogenetics 2013;6:16.
14. Rosenfeld JA, Coe BP, Eichler EE, et al. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet Med 2012;15:478-81.
15. Wright CF, Middleton A, Burton H, et al. Policy challenges of clinical genome sequencing. BMJ 2013;347:f6845.
16. Riggs ER, Church DM, Hanson K, et al. Towards an evidence-based process for the clinical interpretation of copy number variation. Clin Genet 2012;81:403-12.
17. Tadros S, Morrogh D, Scott RH. What is array CGH? Arch Dis Child EducPract Ed 2013;98:134-5.
18. Behjati S, Tarpey PS. What is next generation sequencing? Arch Dis Child EducPract Ed 2013;98:236-8.